SHAREHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2025

Stockholders' Equity Note [Abstract]

Schedule of ordinary shares reserved for future issuance

	June 30, 2025		December 31, 2024
	(Unaudited)

Ordinary shares		51,551,462		50,773,337
Outstanding share options and RSUs		3,032,942		3,164,395
Shares available for future grants under the 2021 plan		10,871,688		8,941,243
Shares available for future grants under the 2024 Foundation plan		14,410		15,000
Shares subject to the employee share purchase plan		1,118,576		1,156,437
Total		66,589,078		64,050,412

Schedule of share option activity

	Number of Options			Weighted-Average Exercise Price		Weighted Average Remaining Contractual life		Aggregate Intrinsic Value
	(Unaudited)
Outstanding — January 1, 2025 (*)		1,768,230		$	62.90		6.04	$	305,379
Granted (*)		42,897		$	0.87
Exercised		(415,101	)	$	38.74
Expired and forfeited		(34,323	)	$	54.03
Outstanding — June 30, 2025		1,361,703		$	68.54		5.68	$	334,903
Exercisable — June 30, 2025 (*)		1,134,484		$	64.20		5.34	$	283,937

(*) Includes 73,074 performance options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, 22,481 in 2024, and 20,217 in 2025, as applicable.

Schedule of unvested restricted stock units

	Number of Units			Weighted-Average Fair Value
	(Unaudited)

Balance at January 1, 2025 (*)		1,396,165		$	177.72
Granted (*)		696,448		$	269.61
Vested		(325,163	)	$	175.71
Canceled		(96,211	)	$	176.79
Balance at June 30, 2025 (*)		1,671,239		$	216.46

(*) Includes 22,928 performance shares granted to the Company’s Co-CEOs in 2023, and 48,129 and 62,211 performance shares granted to the Company’s Co-CEOs and several executives in 2024 and 2025, respectively.

Schedule of share-based compensation expense

	Six months ended June 30,
	2025		2024

Cost of revenues	$	3,406	$	3,116
Research and development		43,347		23,193
Sales and marketing		19,205		18,068
General and administrative		21,645		18,789
Share-based compensation, net of amounts capitalized	$	87,603	$	63,166
Capitalized share-based compensation expense		1,055		648
Total share-based compensation	$	88,658	$	63,814

Schedule of black-scholes stock option assumptions used at the grant dates

	Six months ended June 30,
	2025		2024
	(Unaudited)
Risk-free interest rate		3.74%-4.1%		4.03%-4.77%
Expected dividend yield		0%		0%
Expected term (in years)		2-7		5-7
Expected volatility		57.02%-59.32%		57.81%

monday.com Ltd. 6-K